---
figid: PMC153630__pq0830882006
figtitle: Distinct signaling pathways induced by rhTum and rhEndo
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC153630
filename: pq0830882006.jpg
figlink: /pmc/articles/PMC153630/figure/F6/
number: F6
caption: Schematic illustration of distinct signaling pathways induced by rhTum and
  rhEndo. rhTum binds to αvβ3 integrin, whereas rhEndo binds to α5β1 integrin. Both
  rhEndo and rhTum inhibit phosphorylation of FAK (yellow). Downstream of FAK, rhTum
  inhibits the PI3-K/Akt/mTOR/4EBP1 pathway, resulting in inhibition of endothelial
  protein synthesis and proliferation. MAP kinase pathways are not affected by rhTum.
  In contrast, inhibition of FAK activation by rhEndo binding to α5β1 integrin leads
  to inhibition of ERK1/p38 MAP kinase pathways with no effect on PI3-K/Akt/mTOR/4EBP1
  pathways, resulting in inhibition of endothelial cell migration.
papertitle: Human tumstatin and human endostatin exhibit distinct antiangiogenic activities
  mediated by αvβ3 and α5β1 integrins.
reftext: Akulapalli Sudhakar, et al. Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4766-4771.
year: '2003'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9701277
figid_alias: PMC153630__F6
figtype: Figure
redirect_from: /figures/PMC153630__F6
ndex: e26b4e48-dec8-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC153630__pq0830882006.html
  '@type': Dataset
  description: Schematic illustration of distinct signaling pathways induced by rhTum
    and rhEndo. rhTum binds to αvβ3 integrin, whereas rhEndo binds to α5β1 integrin.
    Both rhEndo and rhTum inhibit phosphorylation of FAK (yellow). Downstream of FAK,
    rhTum inhibits the PI3-K/Akt/mTOR/4EBP1 pathway, resulting in inhibition of endothelial
    protein synthesis and proliferation. MAP kinase pathways are not affected by rhTum.
    In contrast, inhibition of FAK activation by rhEndo binding to α5β1 integrin leads
    to inhibition of ERK1/p38 MAP kinase pathways with no effect on PI3-K/Akt/mTOR/4EBP1
    pathways, resulting in inhibition of endothelial cell migration.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PTK2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - HRAS
  - NRAS
  - MTOR
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MAP2K1
  - MAP2K2
  - MAP3K1
  - EIF4E
  - EIF4E2
  - EIF4E3
  - MAPK3
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - EIF4EBP1
  - scb
  - Fak
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - ras
  - Ras64B
  - Ras85D
  - Mtor
  - Tor
  - Raf
  - Akt
  - Thor
  - Dsor1
  - Mekk1
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4E1
  - eIF4EHP
  - rl
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - Tumstatin
  - Endostatin
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
